Joint Clinical Trials Office

You are here

News

Dr. Selina Chen-Kiang (photo credit: Carlos Rene Perez)
Dr. Selina Chen-Kiang (photo credit: Carlos Rene Perez)

Researchers See Promise for Two New Therapies for Mantle Cell Lymphoma After Discovering Why Tumors Can Become Resistant to a Newly Approved Treatment

The medication was so effective in mantle cell lymphoma, an aggressive, incurable cancer, that the Food and Drug Administration named ibrutinib a "breakthrough" drug. The unprecedented response — 68 percent of patients went into partial or complete remission when they took it — gained the agent accelerated approval last November.

But the disease remains a challenge. Researchers, including those at Weill...

Read More

Researcher's Toolbox

Contact Information

Joint Clinical Trials Office Weill Cornell Medicine /
NewYork-Presbyterian
1300 York Avenue,
Box 305
New York, NY 10065 Phone: (646) 962-8215 Fax: (646) 962-0536

Abbreviation Library